Amgen Inc (AMGN)
307.35
+6.95
(+2.31%)
USD |
NASDAQ |
May 08, 16:00
307.75
+0.40
(+0.13%)
After-Hours: 20:00
Amgen Price to Book Value: 32.83 for May 8, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 32.09 |
| May 06, 2024 | 31.99 |
| May 03, 2024 | 33.25 |
| May 02, 2024 | 29.74 |
| May 01, 2024 | 29.63 |
| April 30, 2024 | 29.26 |
| April 29, 2024 | 29.52 |
| April 26, 2024 | 28.84 |
| April 25, 2024 | 28.77 |
| April 24, 2024 | 29.16 |
| April 23, 2024 | 29.22 |
| April 22, 2024 | 29.04 |
| April 19, 2024 | 28.72 |
| April 18, 2024 | 28.06 |
| April 17, 2024 | 28.20 |
| April 16, 2024 | 28.37 |
| April 15, 2024 | 28.36 |
| April 12, 2024 | 28.55 |
| April 11, 2024 | 28.84 |
| April 10, 2024 | 28.46 |
| April 09, 2024 | 28.88 |
| April 08, 2024 | 28.75 |
| April 05, 2024 | 28.83 |
| April 04, 2024 | 28.63 |
| April 03, 2024 | 29.31 |
| Date | Value |
|---|---|
| April 02, 2024 | 29.50 |
| April 01, 2024 | 30.23 |
| March 31, 2024 | |
| March 28, 2024 | 24.45 |
| March 27, 2024 | 24.62 |
| March 26, 2024 | 24.23 |
| March 25, 2024 | 24.15 |
| March 22, 2024 | 23.75 |
| March 21, 2024 | 23.82 |
| March 20, 2024 | 23.48 |
| March 19, 2024 | 23.37 |
| March 18, 2024 | 23.30 |
| March 15, 2024 | 23.12 |
| March 14, 2024 | 23.35 |
| March 13, 2024 | 23.73 |
| March 12, 2024 | 23.78 |
| March 11, 2024 | 23.68 |
| March 08, 2024 | 23.54 |
| March 07, 2024 | 23.46 |
| March 06, 2024 | 23.79 |
| March 05, 2024 | 23.79 |
| March 04, 2024 | 24.03 |
| March 01, 2024 | 24.11 |
| February 29, 2024 | 23.55 |
| February 28, 2024 | 23.86 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
9.387
Minimum
May 31 2019
149.73
Maximum
May 31 2022
26.49
Average
15.72
Median
Aug 04 2021
Price to Book Value Benchmarks
| Gilead Sciences Inc | 4.637 |
| Johnson & Johnson | 5.120 |
| Eli Lilly and Co | 57.48 |
| Merck & Co Inc | 8.128 |
| Vertex Pharmaceuticals Inc | 5.831 |
Price to Book Value Related Metrics
| PE Ratio | 43.91 |
| PS Ratio | 5.591 |
| Price to Free Cash Flow | 23.26 |
| Price | 307.35 |
| Earnings Yield | 2.28% |
| Market Cap | 164.87B |
| Operating PE Ratio | 23.70 |
| Normalized PE Ratio | 43.91 |